If you have additional
questions or comments on our approach to Extracorporeal Shockwave Therapy or the treatment, don't
hesitate to contact us directly.
Healthcare providers must evaluate patients prior to treatment. To rule out unusual pathologies or specific conditions we ask that imaging studies are made and conditions for treatment are met. More-->
There are relatively few reasons why a patient would be disqualified from a Sonocur treatment. Listed here is a set of conditions that would disqualify a patient. More-->
How the Sonocur works
For a brief explanation of how the Sonocur Extracorporeal Shockwave Therapy device functions and how it affects the physical and chemical composition of tissues: Covered topics include: The Physics of the Device, TENS, Tissue effects and Observed results. More-->
The Sonocur® Orthopedic Extracorporeal Shockwave system is available in Canada and other countries where regulatory approval has been obtained. The Sonocur® Basic is FDA approved in the United States for the treatment of chronic lateral epicondylitis (tennis elbow).
© 2012 Sonorex. All rights reserved. By using this service, you accept the terms of our Visitor Agreement. Please read it. The material sonorex.ca is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.